Published in Blood on April 15, 1995
Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One (2008) 8.97
Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci U S A (2003) 4.09
Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences. Nat Rev Genet (2010) 1.82
The evolving concept of cancer and metastasis stem cells. J Cell Biol (2012) 1.76
Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood (2009) 1.61
A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1999) 1.50
Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cells. Mol Cell Biol (2005) 1.21
FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia. Blood (2006) 1.17
PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors. Leukemia (2009) 1.16
Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures. Mol Cell Biol (2004) 1.10
PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice. J Clin Invest (2011) 1.00
Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors. Cancers (Basel) (2012) 0.85
Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA mice. PLoS One (2012) 0.84
Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemia. Cancer Res (2014) 0.80
All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment. PLoS One (2015) 0.79
Association of acute myeloid leukemia's most immature phenotype with risk groups and outcomes. Haematologica (2016) 0.75
Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med (1996) 2.38
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30
A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell (2001) 2.02
Caspase activation is required for terminal erythroid differentiation. J Exp Med (2001) 1.97
High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood (1995) 1.87
Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology (1988) 1.76
Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med (1985) 1.75
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.72
Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia (2012) 1.60
CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia (2005) 1.59
Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia (1995) 1.58
A new serotyping method for Klebsiella species: evaluation of the technique. J Clin Pathol (1976) 1.56
Computer assisted knee replacement. Clin Orthop Relat Res (1998) 1.53
[Computer-assisted knee arthroplasty: comparison with a conventional procedure. Results of 50 cases in a prospective randomized study]. Rev Chir Orthop Reparatrice Appar Mot (2001) 1.51
Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture. Exp Hematol (1992) 1.49
Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest (1988) 1.48
Update on transcobalamin deficiency: clinical presentation, treatment and outcome. J Inherit Metab Dis (2013) 1.47
Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro. Exp Hematol (2000) 1.43
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann Oncol (2003) 1.40
Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia. Leukemia (2009) 1.33
Production of erythropoietin-like activity by a murine erythroleukemia cell line. Proc Natl Acad Sci U S A (1983) 1.30
A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet (1999) 1.30
How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia (2002) 1.27
Postradiation lower motor neuron syndrome presenting as monomelic amyotrophy. J Neurol Neurosurg Psychiatry (1991) 1.27
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia (2003) 1.21
Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood (1990) 1.20
Characterization and functional analysis of adult human bone marrow cell subsets in relation to B-lymphoid development. Blood (1993) 1.15
Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol (1999) 1.15
Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia. Biochem Biophys Res Commun (2004) 1.15
PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study. Leukemia (2009) 1.14
Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer (1997) 1.13
Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer (1996) 1.13
Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol Cell Biol (1996) 1.11
Rapid, multifluorescent TCRG Vgamma and Jgamma typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations. Leukemia (2000) 1.11
A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines. J Immunol (1989) 1.10
Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance. J Clin Microbiol (2008) 1.08
Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis. Bone Marrow Transplant (2005) 1.07
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group. Leukemia (2006) 1.06
Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol (1997) 1.05
Antigenic analysis of L strain cells: a new murine leukemia-associated antigen, "L". Cancer Res (1970) 1.04
Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol (2000) 1.04
Automated function imaging: a new operator-independent strain method for assessing left ventricular function. Arch Cardiovasc Dis (2008) 1.04
Identification of tissues and cells producing erythropoietin in the anemic mouse. Contrib Nephrol (1988) 1.03
Study of the antigenic specificity of Graffi leukemic cells. J Natl Cancer Inst (1968) 1.02
Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer. Genes Chromosomes Cancer (1996) 1.02
Bodyweight gain and anticonvulsants: a comparative review. Drug Saf (2001) 1.01
[Action of high doses of penicillin G on platelets. Study in Osler's disease]. Nouv Presse Med (1974) 1.01
[The role of immunity in the rejection of tumours induced by the MSV virus. The effect of antithymocyte serums]. Int J Cancer (1968) 1.00
ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues. Int J Cancer (1995) 1.00
Severe but reversible encephalopathy associated with cefepime. Neurophysiol Clin (2000) 1.00
Determinants of brown adipocyte development and thermogenesis. Int J Obes (Lond) (2010) 1.00
The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function. Blood (1996) 0.99
Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood (1996) 0.99
Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation. Leukemia (2007) 0.98
Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures. Blood (1982) 0.98
A hitherto undescribed plasma factor acting at the contact phase of blood coagulation (Flaujeac factor): case report and coagulation studies. Blood (1975) 0.97
Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia (1997) 0.96
Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation. J Clin Pathol (1987) 0.96
Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood (1996) 0.95
The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts. Br J Haematol (1997) 0.95
Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide. Leuk Res (2008) 0.95
Computing power in case-control association studies through the use of quadratic approximations: application to meta-statistics. Ann Hum Genet (2006) 0.94
Multistep virus-induced leukemogenesis in vitro: description of a model specifying three steps within the myeloblastic malignant process. Mol Cell Biol (1984) 0.94
Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5. Blood (1996) 0.93
Polymorphism analysis of JRK/JH8, the human homologue of mouse jerky, and description of a rare mutation in a case of CAE evolving to JME. Epilepsy Res (2001) 0.93
Ion channel variation causes epilepsies. Brain Res Brain Res Rev (2001) 0.93
Role of different lymphocyte subsets in human anti-viral T cell cultures. Cell Immunol (1989) 0.92
Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection. Hum Gene Ther (2000) 0.92
Autocrine function of murine F-MuLV induced myeloblastic cell lines. Int J Cancer (1983) 0.92
Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry (2006) 0.92
Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and 1q25-q31. Ann Neurol (2001) 0.92
Characterization of erythropoietin produced by IW32 murine erythroleukemia cells. Blood (1984) 0.92
[Inflammation of the myocardium as an arrhythmia trigger]. Z Kardiol (2000) 0.92
Chorea and polycythaemia. J Neurol (1985) 0.92
Production of erythropoietin by cloned malignant murine erythroid cells. Exp Hematol (1985) 0.91
Induction of antinuclear antibodies in mice inoculated with Rauscher leukemogenic virus: possible role of genetic factors in "non-New Zealand" strains. Immunol Commun (1973) 0.90
Patient with circulating antibodies to alpha-interferon. Lancet (1981) 0.90
Polycythaemia vera: in vitro studies of circulating erythroid progenitors. Br J Haematol (1980) 0.90
Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis. Arthritis Rheum (1999) 0.90
Pleiotropic syndrome of dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema maps to 16q23-q24. Blood (2000) 0.90
A prospective study of the incidence of delayed haemolytic transfusion reactions following peri-operative blood transfusion. Br J Haematol (1988) 0.90
Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia (2006) 0.89
[Trisomy 20p derived from a maternal pericentric inversion and brachymesophalangy of the index finger]. Ann Genet (1985) 0.89
Malignant myeloblastic transformation of murine long-term bone marrow cultures by F-MuLV: in vitro reproduction of a long-term leukemogenesis, and investigation of preleukemic events. Int J Cancer (1983) 0.89
Antinuclear antibodies in hybrid mice inoculated with parental spleen cells. Biomedicine (1973) 0.89
Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation (2002) 0.89
A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family. Arthritis Rheum (2000) 0.89
Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Haematol (1996) 0.89